Related Experiment Videos
Changes in urinary pathogens and their antibiotic sensitivities, 1971-1992
1Department of Clinical Microbiology, University College Hospital, London, UK.
The Journal of Antimicrobial Chemotherapy
|May 1, 1994
Summary
Urinary pathogen resistance to antibiotics like ampicillin/amoxycillin has increased over 22 years. Ciprofloxacin remains effective against most urinary pathogens, showing less resistance development.
Area of Science:
- Medical Microbiology
- Antimicrobial Resistance
- Public Health
Background:
- Urinary tract infections (UTIs) are common, necessitating ongoing surveillance of pathogen susceptibility.
- Changes in pathogen prevalence and antibiotic resistance patterns impact treatment efficacy.
- Long-term data is crucial for understanding evolving antimicrobial resistance trends.
Purpose of the Study:
- To analyze 22 years of antimicrobial sensitivity data for urinary pathogens from general practice and hospitals.
- To identify trends in pathogen prevalence and antibiotic resistance.
- To inform clinical practice and antimicrobial stewardship.
Main Methods:
- Longitudinal surveillance of unselected urinary pathogens.
- Testing sensitivity to various antimicrobial agents over a 22-year period.
- Analysis of changes in pathogen proportions and resistance patterns.
Main Results:
- Significant shifts in pathogen prevalence observed, including increased Staphylococcus and decreased Proteus mirabilis in general practice.
- Hospital-acquired UTIs showed changes in Klebsiella spp. and Enterobacter spp. proportions.
- Decreased sensitivity to ampicillin/amoxycillin noted in both settings; increasing nalidixic acid resistance linked to Gram-positive pathogens.
- Ciprofloxacin demonstrated broad efficacy with minimal emerging resistance.
Conclusions:
- Antimicrobial resistance patterns for urinary pathogens have evolved significantly over two decades.
- The declining efficacy of older antibiotics like ampicillin/amoxycillin necessitates careful prescribing.
- Ciprofloxacin remains a reliable option for treating UTIs, but ongoing monitoring is essential.